Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor

Inflammatory bowel diseases (IBDs) are chronic conditions of the gastrointestinal tract in which dysregulated immune responses cause persistent inflammation of the gut mucosa. Biologic therapy with anti-TNF blockers has revolutionized the therapeutic management of IBD for their remarkable efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagnini, Cristiano, Pizarro, Theresa T., Cominelli, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611384/
https://www.ncbi.nlm.nih.gov/pubmed/31316377
http://dx.doi.org/10.3389/fphar.2019.00671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611384/
https://www.ncbi.nlm.nih.gov/pubmed/31316377
http://dx.doi.org/10.3389/fphar.2019.00671

Ejemplares similares